Nuwellis, Inc.

NasdaqCM NUWE

Nuwellis, Inc. Revenue for the Trailing 12 Months (TTM) ending September 30, 2024: USD 8.97 M

Nuwellis, Inc. Revenue is USD 8.97 M for the Trailing 12 Months (TTM) ending September 30, 2024, a 3.66% change year over year. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.
  • Nuwellis, Inc. Revenue for the Trailing 12 Months (TTM) ending September 30, 2023 was USD 8.65 M, a 10.27% change year over year.
  • Nuwellis, Inc. Revenue for the Trailing 12 Months (TTM) ending September 30, 2022 was USD 7.85 M, a -5.73% change year over year.
  • Nuwellis, Inc. Revenue for the Trailing 12 Months (TTM) ending September 30, 2021 was USD 8.32 M, a 23.05% change year over year.
  • Nuwellis, Inc. Revenue for the Trailing 12 Months (TTM) ending September 30, 2020 was USD 6.76 M, a 19.87% change year over year.
Key data
Date Revenue Gross Profit Operating Income EBIT
Market news
Loading...
NasdaqCM: NUWE

Nuwellis, Inc.

CEO Mr. Nestor Jaramillo Jr.
IPO Date Feb. 16, 2012
Location United States
Headquarters 12988 Valley View Road
Employees 59
Sector Health Care
Industries
Description

Nuwellis, Inc., a medical device company, focuses on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy. The company's products are the Aquadex FlexFlow and Aquadex SmartFlow systems, which are indicated for the treatment of patients suffering from fluid overload who have failed diuretics. Its Aquadex FlexFlow system includes a console, disposable blood set, and catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors primarily in Austria, Brazil, Czech Republic, Germany, Greece, Hong Kong, India, Israel, Italy, Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.

Similar companies

TNON

Tenon Medical, Inc.

USD 1.67

-3.47%

BJDX

Bluejay Diagnostics, Inc.

USD 3.36

-7.95%

HSCS

Heart Test Laboratories, Inc.

USD 3.26

1.24%

SINT

Sintx Technologies, Inc.

USD 3.21

-4.46%

RSLS

ReShape Lifesciences Inc.

USD 4.66

-6.80%

StockViz Staff

January 15, 2025

Any question? Send us an email